Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-08

Clinical Trial Update: A Study in Men With Benign Prostatic Hyperplasia [Phase 2]

View source ↗

Summary

A Phase 2 study in men with benign prostatic hyperplasia (BPH) was terminated; results were posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Eli Lilly and Company | Conditions: Benign Prostatic Hyperplasia | Phase 2 | Status: TERMINATED | Results posted: 2019-04-08